Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ostene, a new water-soluble bone hemostasis agent.

Tadeusz Wellisz1, Jonathan K Armstrong, John Cambridge

  • 1Division of Plastic and Reconstructive Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

The Journal of Craniofacial Surgery
|June 14, 2006
PubMed
Summary

Ostene, a water-soluble bone hemostasis agent, shows improved biocompatibility compared to traditional bone wax. Ostene does not impede bone healing or cause inflammatory reactions, unlike bone wax formulations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel, Reverse-Phase-Shifting, Thermoreversible Foaming Hydrogel Containing Antibiotics for the Treatment of Traumatic Tissue Injuries in a Swine Model.

Military medicine·2025
Same author

Treatment of Noncompressible Torso Hemorrhage With Thermoreversible Intra-abdominal Foam: A Dose-response Study in a Porcine Model.

The Journal of surgical research·2025
Same author

Novel Thermoreversible Reverse-Phase-Shift Foam With Deployment System for Treatment of Penetrating Globe Trauma in a Newly Described Porcine Model.

Military medicine·2024
Same author

A novel, reverse-phase-shifting, thermoreversible foaming hydrogel containing antibiotics for the treatment of thermal burns in a swine model - A pilot study.

Burns : journal of the International Society for Burn Injuries·2024
Same author

Thermoreversible Reverse-Phase-Shift Foam for Treatment of Noncompressible Torso Hemorrhage, a Safety Trial in a Porcine Model.

Military medicine·2022
Same author

Efficacy of past, present, and future fluid strategies in an improved large animal model of non-compressible intra-abdominal hemorrhage.

The journal of trauma and acute care surgery·2021

Area of Science:

  • Biomaterials Science
  • Surgical Innovation
  • Tissue Engineering

Background:

  • Traditional bone wax, primarily beeswax-based, is associated with adverse tissue reactions and impaired bone healing.
  • Existing bone hemostasis agents present challenges in biocompatibility and osseointegration.

Purpose of the Study:

  • To evaluate the biocompatibility and efficacy of Ostene, a novel water-soluble bone hemostasis agent.
  • To compare the soft tissue and bone healing response to Ostene versus traditional bone wax.

Main Methods:

  • Soft tissue response assessed via paravertebral muscle implantation in rabbits (Ostene, bone wax, polyethylene control).
  • Bone healing assessed in a rabbit femur defect model comparing Ostene and bone wax.
  • Histological analysis evaluated fibrous response, inflammation, and bone ingrowth at 2, 4, and 8 weeks.

Related Experiment Videos

Main Results:

  • Ostene elicited minimal to no fibrous or inflammatory response in soft tissues.
  • Bone wax induced significant fibrous encapsulation and inflammation in soft tissues.
  • In femur defects, Ostene showed no adverse effects, while bone wax caused foreign body reactions and inhibited bone ingrowth.

Conclusions:

  • Ostene demonstrates superior biocompatibility compared to traditional bone wax.
  • Ostene offers a promising alternative for bone hemostasis without compromising bone healing.
  • Water-soluble alkylene oxide copolymers represent a favorable material for bone hemostasis applications.